EpiCept Provides Update on Ceplene® Manufacturing at Ben Venue Laboratories
December 21, 2011 00:01 ET
|
Immune Pharmaceuticals Inc
EpiCept Provides Update on Ceplene® Manufacturing at Ben Venue Laboratories
Supplies Available for Patients in European Union
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--...
EpiCept to Present at the 22nd Annual Wall Street Institutional Investor Conference
November 30, 2011 17:11 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the 22nd Annual Wall Street Institutional Investor
Conference
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq...
EpiCept to Present at the NYSSA Biotech and Specialty Pharma Conference
November 22, 2011 17:01 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at the NYSSA Biotech and Specialty Pharma Conference
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX...
EpiCept Corporation Reports Third Quarter 2011 Operating and Financial Results
November 08, 2011 00:04 ET
|
Immune Pharmaceuticals Inc
EpiCept Corporation Reports Third Quarter 2011 Operating and Financial
Results
Conference Call Begins at 9:00 A.M. Eastern Time
TARRYTOWN, N.Y.--(BUSINESS...
EpiCept to Report Third Quarter 2011 Operating and Financial Results on November 8th, 2011
November 02, 2011 18:06 ET
|
Immune Pharmaceuticals Inc
EpiCept to Report Third Quarter 2011 Operating and Financial Results on
November 8th, 2011
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation...
EpiCept Common Stock to Begin Trading on OTCQX®, The Highest Tier of the OTC Market, on September 19, 2011
September 15, 2011 17:02 ET
|
Immune Pharmaceuticals Inc
EpiCept Common Stock to Begin Trading on OTCQX®, The Highest Tier of the
OTC Market, on September 19, 2011
Withdraws from Nasdaq; Avoids Reverse Split
TARRYTOWN, N.Y.--(BUSINESS...
EpiCept Corporation Provides U.S. Regulatory Update for Ceplene® Clinical Development
September 12, 2011 00:03 ET
|
Immune Pharmaceuticals Inc
EpiCept Corporation Provides U.S. Regulatory Update for Ceplene®
Clinical Development
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation...
EpiCept Common Stock Approved for Primary Listing on OMX Stockholm Exchange
September 07, 2011 00:02 ET
|
Immune Pharmaceuticals Inc
EpiCept Common Stock Approved for Primary Listing on OMX Stockholm
Exchange
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX...
EpiCept to Present at Two Upcoming Industry Conferences
August 31, 2011 17:08 ET
|
Immune Pharmaceuticals Inc
EpiCept to Present at Two Upcoming Industry Conferences
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq and Nasdaq OMX Stockholm...
EpiCept Corporation Reports Second Quarter 2011 Financial Results and Provides Business Update
August 15, 2011 00:03 ET
|
Immune Pharmaceuticals Inc
EpiCept Corporation Reports Second Quarter 2011 Financial Results and
Provides Business Update
Conference Call Begins at 9:00 A.M. Eastern Time Today
TARRYTOWN, N.Y.--(BUSINESS...